Clinical Trial Update: Trial of Ondansetron as a Parkinson's HAllucinations Treatment [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating ondansetron for treating Parkinson's hallucinations and related dementia with Lewy bodies symptoms.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dementia with Lewy Bodies
• Parkinson Disease with Hallucinations

Drugs mentioned

• Ondansetron (ondansetron)

Snippet

Sponsor: University College, London | Conditions: Parkinson's Hallucinations, Dementia With Lewy Bodies | Phase 2 | Status: UNKNOWN